Handelsbanken Fonder Ab Legend Biotech Corp Transaction History
Handelsbanken Fonder Ab
- $25.3 Billion
- Q3 2024
A detailed history of Handelsbanken Fonder Ab transactions in Legend Biotech Corp stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 50,500 shares of LEGN stock, worth $2.12 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
50,500
Previous 46,900
7.68%
Holding current value
$2.12 Million
Previous $2.08 Million
18.49%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding LEGN
# of Institutions
225Shares Held
74.3MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$470 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$316 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$279 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$241 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$212 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $7.04B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...